eMedicine Specialties > Emergency Medicine > Gastrointestinal

Gastroenteritis: Differential Diagnoses & Workup

Author: Arthur Diskin, MD, Vice-President, Global Chief Medical Officer, Royal Caribbean Cruise Lines; Voluntary Associate Professor, University of Miami School of Medicine
Contributor Information and Disclosures

Updated: Oct 22, 2009

Differential Diagnoses

Appendicitis, Acute
Pediatrics, Dehydration
CBRNE - Botulism
Pediatrics, Gastroenteritis
Giardiasis
Salmonella Infection
Hemolytic Uremic Syndrome
Shock, Hypovolemic
Inflammatory Bowel Disease
Obstruction, Large Bowel
Obstruction, Small Bowel

Other Problems to Be Considered

Various infectious etiologies
Pseudomembranous colitis
Food-borne toxigenic diarrhea
Toxins
Hormonal (vasoactive intestinal peptides)
Drugs (ie, sorbitol, cholinergics, caffeine)
Surgery
Radiation colitis
Carcinoid
Pediatrics - Adrenogenital/cystic fibrosis

Workup

Laboratory Studies

  • Determination of laboratory tests: The patient's evaluation should be based on the clinical assessment and the need to do the following:
    • Further evaluate the seriousness of the condition (degree of dehydration and electrolyte derangement).
    • Determine a specific etiologic agent.
    • Evaluate the patient for noninfectious etiologies.
    • Patients who require further workup include those who appear seriously ill or dehydrated; those who have high fevers, bloody stools, severe abdominal pain, or persistent diarrhea; and those who are immunocompromised or whose condition is suspected of having an epidemic diarrheal etiology.
    • History, epidemiologic considerations, and the physical examination should be the primary guides in determining whether any further diagnostic evaluation is necessary, followed by microscopic examination of the stool.
  • Stool studies and culture
    • The presence of blood or leukocytes in stool is a strong indicator of inflammatory diarrhea.
    • Stool studies can be performed efficiently and inexpensively by using a Wright stain or methylene blue and directly observing for leukocytes and performing an occult blood test.
    • Fecal leukocytes are present in 80-90% of all patients with Salmonella or Shigella infections but are less common with other infecting organisms such as Campylobacter and Yersinia. They may also be present in ulcerative colitis and Crohn disease but are usually absent in viral infections, Giardia infection, enterogenic E coli infection, and toxigenic bacterial food poisoning.
    • A stool culture is not necessary or cost-effective in all cases of diarrhea unless a bacterial cause is suspected.
    • A lower threshold for performing stool cultures and examination for ova and parasites is indicated in immunocompromised and immunosuppressed patients.
    • Fever, bloody stools, leukocytes in stool, pain resembling that associated with appendicitis (Yersinia), and diarrheal illness associated with partially cooked hamburger (cytotoxigenic E coli O157:H7) are all indications for culture.
    • Frequently, stool cultures are obtained inappropriately in the United States. Consider whether obtaining a culture would change the therapy.
    • Specific indications for stool cultures include bloody stools, stools that test positive for occult blood or leukocytes, prolonged course of diarrhea that has not been treated with antibiotics, immunocompromised host, or for epidemiologic purposes, such as cases involving food handlers.
    • Routine stool cultures identify only Campylobacter, Shigella, Salmonella, Aeromonas, and Yersinia species.
    • Testing for other pathogens, such as Vibrio species, enterohemorrhagic E coli O157:H7, and other Shigatoxin-producing bacteria require special media. The laboratory should be informed regarding appropriate media for suspected organisms (eg, MacConkey sorbitol agar for E coli O157:H7). Additionally, the laboratory may need to perform specialized testing to specifically identify the organism.
The MacConkey medium is commonly used and differe...

The MacConkey medium is commonly used and differentiates lactose fermenters, which produce acid, decrease the pH, and cause the neutral red indicator to give the colonies a pink-to-red color.

The MacConkey medium is commonly used and differe...

The MacConkey medium is commonly used and differentiates lactose fermenters, which produce acid, decrease the pH, and cause the neutral red indicator to give the colonies a pink-to-red color.


Hektoen enteric agar with <EM>Escherichia coli</E...

Hektoen enteric agar with Escherichia coli colonies. Different growth media are necessary for identifying different enteric pathogens, suppressing the growth of nonpathogens, and allowing for chemical reactions to assist in identification. The appearance results from the organism's ability to ferment lactose placed in the medium. This results in the production of acid, which lowers the pH and causes a change in the pH indicator placed in the medium. Salmonella and Shigella organisms do not ferment lactose.

Hektoen enteric agar with <EM>Escherichia coli</E...

Hektoen enteric agar with Escherichia coli colonies. Different growth media are necessary for identifying different enteric pathogens, suppressing the growth of nonpathogens, and allowing for chemical reactions to assist in identification. The appearance results from the organism's ability to ferment lactose placed in the medium. This results in the production of acid, which lowers the pH and causes a change in the pH indicator placed in the medium. Salmonella and Shigella organisms do not ferment lactose.


Example of <EM>Salmonella</EM> on Hektoen enteric...

Example of Salmonella on Hektoen enteric agar. The medium also contains ferric ammonium citrate, which indicates the production of hydrogen sulfide by the appearance of a black precipitate.

Example of <EM>Salmonella</EM> on Hektoen enteric...

Example of Salmonella on Hektoen enteric agar. The medium also contains ferric ammonium citrate, which indicates the production of hydrogen sulfide by the appearance of a black precipitate.


    • Studies of selected centers have shown that only 2% of stool culture results are positive as routinely obtained. The cost per positive stool culture result has been estimated to be at least $900-1200.
    • Similarly, if parasitic illness is in the differential or if the patient has recently traveled to an endemic region or has chronic diarrhea, the stool should be examined for parasites or their ova with the caveat that several samples may be required to make the diagnosis. Ova and parasite studies are indicated for patients who are immunocompromised, who have a persistent or prolonged course, or whose conditions are unresponsive to antibiotics.
    • Travel to endemic regions followed by chronic diarrhea without signs of acute bacterial diarrhea should prompt a search for a parasitic etiology.
    • Entamoeba histolytica can result in bloody stools, but a smear reveals a lack of leukocytes due to exotoxin produced by the parasite that lyses the cells.
    • Stool can be sent to reference labs for examination for norovirus by PCR. This is usually reserved for epidemiological purposes. Rapid assays are becoming available with varying sensitivities and questionable clinical applicability.
  • Routine laboratory tests
    • Routine laboratory tests (CBC, electrolytes, renal function) may not be helpful or indicated in making a diagnosis. These tests may be useful as indicators of severity of disease, especially in elderly or very young patients, although that determination is best made clinically.
    • Electrolytes and BUN tests are indicated in patients with severe diarrhea or dehydration to rule out hyponatremia or hypernatremia. Decreased serum bicarbonate suggests severe dehydration, especially in children. Acidosis secondary to bicarbonate loss in the stools and/or from hypovolemia-induced lactic acidosis may be present. Hypokalemia may also occur.
    • A CBC may be indicated with a prolonged course, severe diarrhea, or toxicity. The WBC count is usually increased in Salmonella infections but normal or low with significant left shift in Shigella infections. The WBC count is otherwise variable. Eosinophilia may be present in parasitic infections.
  • Enzyme-linked immunosorbent assay
    • Commercially available immunofluorescent antibody and enzyme immunoassays are also available for Giardia and Cryptosporidium organisms. C difficile toxin assays can be performed when antibiotic-associated diarrhea is suspected.
    • Rotavirus: Enzyme-linked immunosorbent assay (ELISA) is available in less than 2 hours but is not sensitive enough in adults.
    • Giardia: ELISA is more than 90% sensitive in susceptible populations (eg, people who camp or travel to endemic areas). Consider ELISA prior to ova and parasite examination or string test.

Imaging Studies

  • An acute abdominal series is indicated only when bowel obstruction, toxic megacolon, or perforation is suspected.

Procedures

  • Sigmoidoscopy may be indicated if pseudomembranous colitis or inflammatory bowel disease is suspected. Sigmoidoscopy is useful in obtaining tissue for culture in patients with AIDS who have undiagnosed diarrhea or wasting syndrome.

More on Gastroenteritis

Overview: Gastroenteritis
Differential Diagnoses & Workup: Gastroenteritis
Treatment & Medication: Gastroenteritis
Follow-up: Gastroenteritis
Multimedia: Gastroenteritis
References

References

  1. Centers for Disease Control and Prevention. Vessel Sanitation Program: Cruise Ship Outbreak Updates. Available at http://www.cdc.gov/nceh/vsp/surv/GIlist.htm.

  2. Centers for Disease Control and Prevention. Vessel Sanitation Program: Cruise Ship Inspection. Available at http://wwwn.cdc.gov/InspectionQueryTool/Forms/InspectionSearch.aspx.

  3. Centers for Disease Control and Prevention. Investigation Update: Outbreak of Salmonella Typhimurium Infections, 2008–2009. Available at http://www.cdc.gov/salmonella/typhimurium/update.html.

  4. [Best Evidence] Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. Jan 5 2006;354(1):11-22. [Medline].

  5. DuPont HL, Jiang ZD, Okhuysen PC, Ericsson CD, de la Cabada FJ, Ke S, et al. A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med. May 17 2005;142(10):805-12. [Medline].

  6. Caeiro JP, DuPont HL. Management of travellers' diarrhoea. Drugs. Jul 1998;56(1):73-81. [Medline].

  7. CDC. Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep. Dec 13 2002;51(49):1112-5. [Medline][Full Text].

  8. Dolin R. Noroviruses--challenges to control. N Engl J Med. Sep 13 2007;357(11):1072-3. [Medline].

  9. [Guideline] DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. Nov 1997;92(11):1962-75. [Medline].

  10. Gonenne J, Pardi DS. Clostridium difficile: an update. Compr Ther. Fall-Winter 2004;30(3):134-40. [Medline].

  11. [Guideline] Guerrant RL, Van Gilder T, Steiner TS, Thielman NM, Slutsker L, Tauxe RV, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. Feb 1 2001;32(3):331-51. [Medline].

  12. Health Protection Agency Centre for Infections. Guidance for the Management of Norovirus Infection in Cruise Ships - Norovirus Working Group. Available at http://www.hpa.org.uk/publications/2007/cruiseliners/cruiseliners.pdf.

  13. Musher DM, Musher BL. Contagious acute gastrointestinal infections. N Engl J Med. Dec 2 2004;351(23):2417-27. [Medline].

  14. Seamens CM, Schwartz G. Food-borne illness: differential diagnosis and targeted management. Emerg Med Rep. 1998;19:120-131.

  15. Teitelbaum JE. Probiotics and the treatment of infectious diarrhea. Pediatr Infect Dis J. Mar 2005;24(3):267-8. [Medline].

  16. Thielman NM, Guerrant RL. Clinical practice. Acute infectious diarrhea. N Engl J Med. Jan 1 2004;350(1):38-47. [Medline].

  17. Widdowson MA, Glass R, Monroe S, Beard RS, Bateman JW, Lurie P, et al. Probable transmission of norovirus on an airplane. JAMA. Apr 20 2005;293(15):1859-60. [Medline].

Further Reading

Contributor Information and Disclosures

Author

Arthur Diskin, MD, Vice-President, Global Chief Medical Officer, Royal Caribbean Cruise Lines; Voluntary Associate Professor, University of Miami School of Medicine
Arthur Diskin, MD is a member of the following medical societies: American College of Emergency Physicians
Disclosure: Royal Caribbean Cruise Lines Salary Employment

Medical Editor

Michelle Ervin, MD, Chair, Department of Emergency Medicine, Howard University Hospital
Michelle Ervin, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, National Medical Association, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Eugene Hardin, MD, FAAEM, FACEP, Former Chair and Associate Professor, Department of Emergency Medicine, Charles Drew University of Medicine and Science; Former Chair, Department of Emergency Medicine, Martin Luther King Jr/Drew Medical Center
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Steven C Dronen, MD, FAAEM, Director of Emergency Services, Director of Chest Pain Center, Department of Emergency Medicine, Ft Sanders Sevier Medical Center
Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.